How to get a Certificate of Attendance
- Complete the event evaluation
- Your certificate of attendance will automatically be send by email.
In accordance with the guidelines of the European Union of Medical Specialists (UEMS), the completion of the event evaluation is prerequisite for obtaining a certificate of attendance.
How to get a Record of Attendance?
- Fill in the session evaluation form for each session you attended and contact us at [email protected] in order to obtain the document
When is the deadline to evaluate?
July 23, 2026
Session Evaluation
IOFC 111 – Essentials of oncology (12:00 – 13:15)
Evaluate
BRCR 112 – Breast cancer and thermal ablation: how to build a practice? (12:00 – 13:00)
Evaluate
BRCR 122 – Hands-on session (13:00 – 14:30)
Evaluate
IOFC 121 – Lung cancer and lung metastases (13:20 – 14:20)
Evaluate
IOFC 131 – Renal cell carcinoma (14:25 – 15:25)
Evaluate
BRCR 132 – Why and how a cryoablation on breast tumours? (15:30 – 16:30)
Evaluate
IOFC 141 – Breast cancer (16:00 – 17:00)
Evaluate
BRCR 142 – Pushing the boundaries (16:40 – 17:50)
Evaluate
IOFC 151 – Primary liver cancer and liver metastases (17:00 – 18:00)
Evaluate
HDT-TA 21.1 – Tumour ablation: heat-based ablation (08:30 – 10:00)
Evaluate
CF 211 – Pushing the boundaries in HCC management: new horizons in… (08:30 – 10:00)
Evaluate
HDT-TA 22.1 – Tumour ablation: cold-based ablation (10:30 – 12:00)
Evaluate
CF 221 – Mastering local treatment of metastatic colorectal cancer (10:30 – 12:00)
Evaluate
WS 22.2 – Workshop: Mastering communication in patient care (10:30 – 12:00)
Evaluate
CF 222 – Defining success in renal IO: outcomes that drive practice (10:30 – 12:00)
Evaluate
CF 243 – Shaping the future of IR: leadership, collaboration, and training across borders (15:00 – 16:30)
Evaluate
HDT-TA 24.1 – Tumour ablation: non-thermal ablation (15:00 – 16:30)
Evaluate
WS 24.2 – Workshop: Collaborative decisions that count – enhancing MDT effectiveness (15:00 – 16:30)
Evaluate
CF 242 – Immunotherapy: a snapshot of the opportunities and challenges for interventional oncology (15:00 – 16:30)
Evaluate
EM 241 – ECIO meets ESMO Breast Cancer (15:00 – 16:30)
Evaluate
BC 253 – Basic course: lung – the essentials (17:00 – 19:00)
Evaluate
HDT-TA 25.1 – Tumour ablation: confirmation software (17:00 – 18:30)
Evaluate
TF 251 – How to perform a safe and effective procedure: a step-by-step approach (1) (17:00 – 18:30)
Evaluate
CF 252 – Setting standards, building evidence and driving impact in IO (17:00 – 18:30)
Evaluate
HDT-RE 31.2 – Radioembolization: dosimetry and administration systems (08:30 – 10:30)
Evaluate
CF 312 – Spinal metastases: multidisciplinary management (08:30 – 10:00)
Evaluate
HDT-TA 31.1 – Tumour ablation: confirmation software (08:30 – 10:00)
Evaluate
TB 311 – Tumour Board: lung (08:30 – 10:00)
Evaluate
SP 313 – Thermal and non-thermal liver tumour ablation (08:30 – 10:00)
Evaluate
HL 321 – Thierry de Baère Lecture (10:30 – 11:15)
Evaluate
HDT-TA 32.1 – Tumour ablation: non-thermal ablation (10:30 – 12:00)
Evaluate
HT 322 – Breakthroughs in interventional oncology (11:15 – 12:00)
Evaluate
HDT-TA 34.1 – Tumour ablation: cold-based ablation (15:00 – 16:30)
Evaluate
TB 341 – Tumour Board: colorectal cancer (15:00 – 16:30)
Evaluate
EM 342 – ECIO meets EUROSPINE: current trends of treating spinal metastases (15:00 – 16:30)
Evaluate
HDT-RE 34.2 – Radioembolization: dosimetry and administration systems (15:00 – 17:00)
Evaluate
SP 343 – IO from brain to pelvis (15:00 – 16:30)
Evaluate
IA 352.1 – Structured IO pathways: delivering excellence in ablation care at IASIOS centres (17:00 – 18:00)
Evaluate
BC 353 – Basic course: lung – the primary lung cancer (17:00 – 19:00)
Evaluate
HDT-TA 35.1 – Tumour ablation: heat-based ablation (17:00 – 18:30)
Evaluate
CF 351 – Ask me anything: an MDT approach to patient care (17:00 – 18:30)
Evaluate
HDT-TA 41.1 – Tumour ablation: non-thermal ablation (08:30 – 10:00)
Evaluate
CF 411 – HCC in metabolic dysfunction-associated steatotic liver disease (MASLD): a world of challenges and opportunities (08:30 – 10:00)
Evaluate
SP 413 – Y90 and novel therapies (08:30 – 10:00)
Evaluate
CF 412 – Management of extra-spinal bone metastases (08:30 – 10:00)
Evaluate
CF 421 – Oligometastatic disease: navigating through the natural reserve of local ablative treatments (10:30 – 12:00)
Evaluate
HDT-MSK 42.2 – Musculoskeletal oncologic interventions (10:30 – 12:00)
Evaluate
CF 422 – What can the interventional radiologist do in the treatment of non-colorectal liver metastases? (10:30 – 12:00)
Evaluate
HDT-TA 42.1 – Tumour ablation: heat-based ablation (10:30 – 12:00)
Evaluate
CF 423 – Cancer as a chronic disease (10:30 – 12:00)
Evaluate
EM 442 – ECIO meets E-AHPBA: Cut or burn? When surgeons and interventional oncologists team up (15:00 – 16:30)
Evaluate
TF 441 – How to perform a safe and effective procedure: a step-by-step approach (2) (15:00 – 16:30)
Evaluate
CF 443 – Meet the PI (15:00 – 16:30)
Evaluate
HDT-MSK 44.2 – Musculoskeletal oncologic interventions (15:00 – 16:30)
Evaluate
HDT-TA 44.1 – Tumour ablation: cold-based ablation (15:00 – 16:30)
Evaluate
CF 452 – Smart tools, smarter IO (17:00 – 18:30)
Evaluate
TB 451 – Tumour Board: renal cancer (17:00 – 18:30)
Evaluate
BC 453 – Basic course: lung – the metastatic disease (17:00 – 19:00)
Evaluate
Is it possible to claim certificates for past congresses?
Claiming certificates for past congresses is possible if you had a valid registration for the respective event and completed the necessary evaluation form(s). Please note that Records of Attendance for congresses held before 2022 cannot be issued anymore.